Table 2.
COVID-19 characteristics of selected U.S. states as of July 9, 2020
| State | Number of cases | Number of deaths | %* | Designation pattern | Peak timinga |
|---|---|---|---|---|---|
| New York | 399,575 | 31,980 | 8.0 | A | early |
| California | 300,324 | 6,849 | 2.3 | B | late |
| Florida | 232,718 | 4,009 | 1.7 | B | late |
| Texas | 230,346 | 2,918 | 1.3 | B | late |
| New Jersey | 174,628 | 15,479 | 8.9 | A | early |
| Illinois | 150,450 | 7,119 | 4.7 | A | early |
| Arizona | 112,671 | 2,038 | 1.8 | B | late |
| North Carolina | 79,349 | 1,460 | 1.8 | C | none |
| Connecticut | 47,209 | 4,348 | 9.2 | A | early |
| Utah | 27,519 | 202 | 0.7 | C | none |
| District of Columbia | 10,743 | 568 | 5.3 | A | early |
*The difference in relative mortality rate between Type A and Type B states, as well as between Type A and Type A+B states was highly significant (P < 0.0001), with Type A states experiencing significantly higher mortality
a“Early,” denotes disease peaks in April and May; “late,” denotes disease peaks in June and July